Mitchell S. von Itzstein

673 citations
37 papers · 462 · h-index 12

Impact in

    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Immunotherapy and Biomarkers 12
    • CAR-T cell therapy research 1
    • Immunotherapy and Immune Responses 3
    • Immune Cell Function and Interaction 2

Mitchell S. von Itzstein

37 papers receiving 460 citations

Peers

Mitchell S. von Itzstein
Comparison fields: 5 of 61
  • Health Informatics 16
  • Oncology 226
  • Pulmonary and Respiratory Medicine 89
  • Immunology 53
  • Cancer Research 28
Replace Tomoya Tago with:
Tomoya Tago Japan
Martín Osvaldo Angel Argentina
Henriette C. Jodal Norway
Sarah Jo Stephens United States
Maiwand Ahmadsei Switzerland
Toulsie Ramtohul France
Perrine Vuagnat France
Guoqiang Wang China
Gabriela Sousa Portugal
M. Guirado Spain
Mitchell S. von Itzstein relative to Tomoya Tago Japan Tomoya Tago's profile →
Citations per field
00.5×2×3.2×
Tomoya Tago · 1×
Citations per year

Countries citing papers authored by Mitchell S. von Itzstein

Since Specialization
Citations

This map shows the geographic impact of Mitchell S. von Itzstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell S. von Itzstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell S. von Itzstein more than expected).

Fields of papers citing papers by Mitchell S. von Itzstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell S. von Itzstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell S. von Itzstein. The network helps show where Mitchell S. von Itzstein may publish in the future.

Co-authors

The 25 scholars most cited alongside Mitchell S. von Itzstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell S. von Itzstein Line = papers co-authored together Mitchell S. von Itzstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1 202099
2 202133
3 202226
4 202124
5 202422
6 202021
7 202020
8 201919
9 202217
10 201816
11 202013
12 202013
13 202012
14 201910
15 202110
16 202410
17 20229
18 20229
19 20259
20 20178

About Mitchell S. von Itzstein

Mitchell S. von Itzstein is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Genetics and Cancer Research, having authored 37 papers that have together received 462 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (12 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Diagnosis and Treatment (3 papers), Immunotherapy and Immune Responses (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Treatments and Mutations (3 papers), Immune Cell Function and Interaction (2 papers) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Health Informatics (16 citations), Oncology (226 citations), Pulmonary and Respiratory Medicine (89 citations), Immunology (53 citations) and Cancer Research (28 citations). Mitchell S. von Itzstein has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include David E. Gerber, Shaheen Khan, Yang Jin Xie, Farjana Jahan Fattah, Helen Mayo, Jennifer A. Whitaker, John Dorrance Minna, Rong Lü, Jason Y. Park and Edward K. Wakeland. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, The Oncologist, The Cancer Journal, Cancer and Clinical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact